| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.
|
Eur Heart J
|
2004
|
1.98
|
|
2
|
Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group).
|
Am J Cardiol
|
2006
|
1.87
|
|
3
|
Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study).
|
Am J Cardiol
|
2010
|
1.78
|
|
4
|
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
|
J Am Coll Cardiol
|
2002
|
1.66
|
|
5
|
High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure.
|
Eur Heart J
|
2005
|
1.64
|
|
6
|
Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging.
|
Eur Radiol
|
2008
|
1.63
|
|
7
|
Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.
|
Circ Res
|
2014
|
1.60
|
|
8
|
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction.
|
Eur Heart J
|
2004
|
1.59
|
|
9
|
Right ventricular systolic function in organic mitral regurgitation: impact of biventricular impairment.
|
Circulation
|
2013
|
1.58
|
|
10
|
Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction.
|
Circulation
|
2008
|
1.56
|
|
11
|
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure.
|
Am Heart J
|
2005
|
1.53
|
|
12
|
Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction.
|
Eur Heart J
|
2005
|
1.52
|
|
13
|
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
|
Am Heart J
|
2006
|
1.48
|
|
14
|
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
|
J Am Coll Cardiol
|
2004
|
1.42
|
|
15
|
Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitors.
|
Chest
|
2003
|
1.42
|
|
16
|
Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest.
|
Am Heart J
|
2008
|
1.40
|
|
17
|
An unusual case of papillary fibroelastoma "invading" the mitral valve.
|
J Thorac Cardiovasc Surg
|
2006
|
1.38
|
|
18
|
Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients.
|
J Am Coll Cardiol
|
2002
|
1.35
|
|
19
|
Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest.
|
J Card Fail
|
2008
|
1.26
|
|
20
|
Prevalence and determinants of cognitive impairment in chronic heart failure patients.
|
Congest Heart Fail
|
2007
|
1.07
|
|
21
|
Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction.
|
Am J Cardiol
|
2012
|
1.06
|
|
22
|
Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation.
|
Heart
|
2010
|
1.05
|
|
23
|
Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.
|
Pharmacogenet Genomics
|
2005
|
1.04
|
|
24
|
The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.
|
Am Heart J
|
2007
|
0.97
|
|
25
|
The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure.
|
Eur J Heart Fail
|
2005
|
0.93
|
|
26
|
Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters.
|
Eur Heart J
|
2012
|
0.89
|
|
27
|
Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis.
|
Proteomics
|
2008
|
0.88
|
|
28
|
Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.
|
Am Heart J
|
2008
|
0.88
|
|
29
|
Decreased serine207 phosphorylation of troponin T as a biomarker for left ventricular remodelling after myocardial infarction.
|
Eur Heart J
|
2010
|
0.87
|
|
30
|
Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling.
|
Proteomics Clin Appl
|
2011
|
0.87
|
|
31
|
Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
|
Eur Heart J
|
2005
|
0.86
|
|
32
|
Deep plasma proteomic analysis of patients with left ventricular remodeling after a first myocardial infarction.
|
Proteomics Clin Appl
|
2010
|
0.83
|
|
33
|
Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus.
|
J Cardiovasc Med (Hagerstown)
|
2012
|
0.83
|
|
34
|
Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure.
|
Eur J Heart Fail
|
2004
|
0.83
|
|
35
|
Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.
|
Arch Cardiovasc Dis
|
2010
|
0.83
|
|
36
|
Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
|
Am Heart J
|
2004
|
0.83
|
|
37
|
Left ventricular remodeling is associated with the severity of mitral regurgitation after inaugural anterior myocardial infarction--optimal timing for echocardiographic imaging.
|
Am Heart J
|
2008
|
0.81
|
|
38
|
Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
|
Cardiovasc Revasc Med
|
2009
|
0.81
|
|
39
|
Prognostic importance of tissue Doppler-derived diastolic function in patients presenting with acute coronary syndrome: a bedside echocardiographic study.
|
Eur J Echocardiogr
|
2008
|
0.81
|
|
40
|
Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotion.
|
Am J Hypertens
|
2009
|
0.81
|
|
41
|
Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
|
PLoS One
|
2013
|
0.81
|
|
42
|
Strategy for purification and mass spectrometry identification of SELDI peaks corresponding to low-abundance plasma and serum proteins.
|
J Proteomics
|
2010
|
0.80
|
|
43
|
Poor agreement between light transmission aggregometry, Verify Now P2Y₁₂ and vasodilatator-stimulated phosphoprotein for clopidogrel low-response assessment: a potential explanation of negative results of recent randomized trials.
|
Platelets
|
2013
|
0.80
|
|
44
|
A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions.
|
BMC Cardiovasc Disord
|
2005
|
0.80
|
|
45
|
First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.
|
Arch Cardiovasc Dis
|
2013
|
0.79
|
|
46
|
Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study.
|
Circ Heart Fail
|
2013
|
0.79
|
|
47
|
Prospective aortic screening in men with coronary aneurysms.
|
J Am Coll Cardiol
|
2006
|
0.79
|
|
48
|
Association of OAZ1 gene polymorphisms with subclinical and clinical vascular events.
|
Arterioscler Thromb Vasc Biol
|
2007
|
0.79
|
|
49
|
The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction.
|
Eur Heart J
|
2008
|
0.79
|
|
50
|
Protective effects of basic fibroblast growth factor in early atherosclerosis.
|
Growth Factors
|
2004
|
0.78
|
|
51
|
Polyarteritis nodosa-related coronary aneurysms.
|
J Rheumatol
|
2008
|
0.78
|
|
52
|
Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms.
|
Thromb J
|
2003
|
0.78
|
|
53
|
White blood cell and peripheral blood mononuclear cell counts for the prediction of left ventricular remodeling after myocardial infarction.
|
J Cardiol
|
2011
|
0.78
|
|
54
|
Incidence, determinants and consequences of left atrial remodelling after a first anterior myocardial infarction.
|
Arch Cardiovasc Dis
|
2012
|
0.77
|
|
55
|
Circulating levels of soluble Fas ligand and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study).
|
J Cardiol
|
2012
|
0.77
|
|
56
|
Relation of admission white blood cell count to left ventricular remodeling after anterior wall acute myocardial infarction.
|
Am J Cardiol
|
2007
|
0.77
|
|
57
|
Impact of thrombus aspiration use and direct stenting on final myocardial blush score in patients presenting with ST-elevation myocardial infarction.
|
Cardiovasc Revasc Med
|
2010
|
0.77
|
|
58
|
Angioplasty in the diabetic patient.
|
J Invasive Cardiol
|
2004
|
0.76
|
|
59
|
Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study).
|
Eur J Heart Fail
|
2011
|
0.76
|
|
60
|
High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis.
|
Catheter Cardiovasc Interv
|
2008
|
0.76
|
|
61
|
Cardiac correlates of exercise induced pulmonary hypertension in patients with chronic heart failure due to left ventricular systolic dysfunction.
|
Echocardiography
|
2008
|
0.76
|
|
62
|
New technologies, new therapies: toward personalized medicine in heart failure patients?
|
Eur Heart J
|
2012
|
0.76
|
|
63
|
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients.
|
Am Heart J
|
2007
|
0.75
|
|
64
|
Left ventricular remodeling and heart failure after myocardial infarction in elderly patients.
|
Am J Cardiol
|
2010
|
0.75
|
|
65
|
High-sensitivity C-reactive protein for risk stratification in patients with heart failure.
|
Am Heart J
|
2008
|
0.75
|
|
66
|
Nature of coronary disease in patients with insulin resistance and its impact on revascularization strategies.
|
Coron Artery Dis
|
2005
|
0.75
|
|
67
|
Long-term prognostic value of preprocedural adiponectin levels in patients undergoing percutaneous coronary intervention.
|
Int J Cardiol
|
2013
|
0.75
|
|
68
|
Myocardial metastasis of a bronchial carcinoid.
|
Eur Heart J
|
2006
|
0.75
|
|
69
|
Clopidogrel Use as Single Antiplatelet Therapy in Outpatients with Stable Coronary Artery Disease: Prevalence, Correlates and Association with Prognosis (from the CORONOR Study).
|
Cardiology
|
2016
|
0.75
|
|
70
|
[What is the place of beta-adrenergic blockade therapy in coronary syndromes in the modern management era?].
|
Therapie
|
2006
|
0.75
|
|
71
|
Effect of aspirin in addition to oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation.
|
Panminerva Med
|
2016
|
0.75
|
|
72
|
[Is there a role for calcium antagonists when beta-adrenergic blockade therapy is contraindicated in post-myocardial infarction?].
|
Therapie
|
2006
|
0.75
|
|
73
|
Prospective assessment of multiple cardiac papillary fibroelastomas: an echocardiographic and surgical study.
|
Int J Cardiol
|
2010
|
0.75
|
|
74
|
Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.
|
Hosp Pract (1995)
|
2010
|
0.75
|
|
75
|
Impact of initial clinical presentation on clopidogrel low response.
|
Arch Cardiovasc Dis
|
2013
|
0.75
|
|
76
|
[Not Available].
|
Therapie
|
2016
|
0.75
|